Cite
HARVARD Citation
Seelig, D. et al. (2017). Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies. Leukemia & lymphoma. 58 (7), pp. 1702-1710. [Online].